Trial intelligence / Profile preview

Intranasal Oxytocin in Moderate to Heavy Social Alcohol Drinkers

NCT01829516Phase 4Completed

Sponsor
University of California, San Francisco
Start
May 2013
Primary completion
May 2014
Countries
1
01

Overview

A Phase 4 trial of oxytocin nasal spray in alcohol use disorder (AUD), sponsored by University of California, San Francisco. Started May 2013; status: completed.

02

Drugs

oxytocin nasal spray
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT01829516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01829516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call